Prevalence of Primary Aldosteronism in Atrial Fibrillation

Prevalence of Primary Aldosteronism in Patients With Atrial Fibrillation (ERETRIA Trial)

This is an observational prospective cross-sectional study, investigating the prevalence of primary aldosteronism in patients with atrial fibrillation.

Inclusion Criteria:

• Established diagnosis of atrial fibrillation with a standard surface ECG tracing of at least 30 seconds (either paroxysmal or persistent or permanent).

Exclusion Criteria:

• Diagnosis of primary aldosteronism
• Diagnosis of heart failure, treated with mineralocorticoid receptor antagonists
• Inability to be subjected to any confirmatory tests for primary aldosteronism
• Acute vascular event (acute coronary syndrome, stroke, acute peripheral vascular event) within last 6 months
• Renal replacement therapy
• Incompetence of unwillingness to provide written informed consent